Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Several studies focused on this topic were recently reported on at the AACR-Melanoma Conference.
HIV, anti-vaxxers, dengue fever and weak primary health care make the World Health Organization’s list of priorities.
The discovery points the way toward a new strategy for precision cancer therapy.
In tumors with missing or mutated BRCA genes, PARP inhibitors plus other drugs have worked well—but the cancer often becomes drug-resistant.
Dietary or drug interventions could counteract resistance to PI3K inhibitors in many tumors.
This finding could lead to clinical trials specifically for men with treatment-emergent small-cell neuroendocrine prostate cancer.
Treatment-resistant cancers self-destruct when exposed to experimental drug.
The cells’ immediate response was to change the mechanisms they use to evade treatment and start dividing again—in just a few days.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.